Cannabis and CBD Sales Projected to Show Strength

Wednesday, May 23, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FinancialBuzz.com News Commentary

NEW YORK, May 23, 2018 /PRNewswire/ --

A market report by Ameri Research

Inc. indicates that the global legal cannabis market was valued at $14.3 billion in 2016 and is expected to grow at a CAGR of 21.1% from 2017 to 2024. During the forecast period, the projected demand of legal cannabis products
will continue to rise for both recreational and medical use with estimated global sales value to reach $63.5 billion. The legal cannabis market is witnessing robust growth thanks to successful legalization and decriminalization campaigns across North America and Europe. Ameri Research also explained that due to the complex regulatory structure at the state level and federal level, the full potential of the market is not yet realized. Chineseinvestors.com, Inc. (OTC: CIIX), CV Sciences, Inc. (OTC: CVSI), Freedom Leaf Inc. (OTC: FRLF), Medical Marijuana, Inc. (OTC: MJNA), NightFood Holdings, Inc. (OTC: NGTF)

A major component of the legal cannabis industry is the CBD market. CBD is the part of the cannabis plant that doesn't have any psychotropic effects, and is typically used for medical purposes. Matt Karnes of Greenwave Advisors is optimistic about the growth of the CBD market saying, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only - this is in addition to the 28 states plus DC that have legalized medical marijuana," Forbes reported. Outco, the largest licensed cultivator in Southern California learned that 38% of users and non-users said they wanted to learn more about CBD oil. Forbes indicated that Outco also believes the market is poised for growth.

Chineseinvestors.com, Inc. (OTCQB: CIIX) earlier this week announced breaking news that, "Its wholly owned subsidiary, ChineseHempOil.com, Inc. ("ChineseHempOil") has expanded its domestic sales force appointing Nina Wang Vice President of Sales for its United States Consumer Retail/E-Commerce Division on March 19, 2018, setting the stage to complete the temporarily postponed spin off of all of the Company's hemp related assets in the near future.

Mrs. Wang has over 15 year's sales experience in the financial services industry with over 10 years as a Merchant Services Sales Manager at USA First Credit Card, Inc. Prior to that, Mrs. Wang worked as a Sales Manager for Alliance Bank Card Services. Since joining ChineseHempOil.com, Inc. in March 2018, Mrs. Wang has hired a team of sales representatives focused on wholesale and consignment sales in the Los Angeles area.  

Through her efforts, ChineseHempOil.com, Inc. has developed strategic relationships with over 70 retail establishments in the Los Angeles area to consign the ChineseHempOil OptHemp products with plans to expand to Northern California in the near future. Mrs. Wang will also play an integral role in procuring new manufacturing relationships to, continuing to brand the Opt Hemp product line and developing new cutting edge hemp products.

"With over 15 years sales and management experience, we look forward to the increased sales that will be generated through Mrs. Wang's leadership as we are laying the groundwork to increase revenues in advance of the spin-off of all of the Company's hemp related assets. We were pleased with the 57% increase in monthly sales generated by the recent Mother's Day Promotion and are looking forward to an even better response for the Father's Day promotion," said Warren Wang CEO.

The Company recently announced in an 8k filing that spin-off of all of the Company's hemp related assets, originally scheduled for May 31, 2018, has been temporarily postponed as it continues to develop its domestic sales channels."

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. Recently, the company announced its financial results for the first quarter ended March 31, 2018. Sales for Q1 2018 were $8.1 million demonstrating the Company's continued organic expansion into all sales channels including the natural product retail, wholesale and direct-to-consumer channels. CV Sciences plans to continue developing new sales channels and is encouraged by the strength of its branded products as evidenced by SPINS® Scan data, which positions the Company as the #l selling hemp product line in the natural products industry.

Freedom Leaf Inc. (OTCQB: FRLF), is a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies. FRLF's large portfolio of acquisitions and properties includes: its wholly-owned hemp extraction division Leafceuticals, Inc., its exclusive health and wellness CBD brand Hempology, its 60,000 acres of indoor hemp greenhouse cultivation and 200 acres of outdoor cultivation with Green Market Europe, its hemp-based rolling paper company Plants to Paper, two of the largest Spanish-speaking cannabis web portals in the world LaMarihuana.com and Marihuana-Medicinal.com, and of course our flagship publication, Freedom Leaf Magazine. On April 17, 2018, the company consummated its previously-announced acquisition of the Irie CBD Product Line, including virtually all: assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line that, and has been operating since 2015, it formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets across the country.

Medical Marijuana, Inc. (OTC: MJNA) recently announced that portfolio company Kannalife Sciences, Inc., a bio-pharmaceutical and phyto-medical company, was featured in a Dateline NBC segment discussing how their research on cannabidiol (CBD)-like molecules could potentially change the landscape for various ailments including chronic traumatic encephalopathy (CTE) and the opioid epidemic. Kannalife currently holds two licenses, one of them exclusive, with the National Institutes of Health (NIH) for the Commercialization of U.S. Patent #6630507, "Cannabinoids as Antioxidants and Neuroprotectants," to research Hepatic Encephalopathy (HE) and CTE.

NightFood Holdings, Inc. (OTC: NGTF), operates both NightFood, Inc. and MJ Munchies, Inc. MJ Munchies was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. On March 23, 2018, MJ Munchies provided an update on the development of its Half-Baked line of cannabis-related snacks. After further research, the Company decided to move forward with Project X in January. One of the leading nutraceutical consulting firms in the United States has been engaged to drive product development and formulation under the guidance of NightFood's Peter Leighton. In addition to the development of these unique products, which it plans to launch under the Half-Baked trademark, MJ Munchies is also currently in discussions with manufacturers regarding the launch of THC infused recreational snacks in Washington, Colorado, and Nevada. 

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For chineseinvestors.com Inc. financial news dissemination and PR services, FinancialBuzz.com expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.

For further information: Media Contact: info@financialbuzz.com +1-877-601-1879 Url: http://www.FinancialBuzz.com  

SOURCE FinancialBuzz.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store